XML 35 R23.htm IDEA: XBRL DOCUMENT
v3.26.1

Net (Loss) Income per Share (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2026
Earnings Per Share [Abstract] |
Schedule of Reconciliation of the Numerator and Denominator Used in the Calculation of Basic and Diluted Net Income (Loss) per Share of Class A Common Stock | A reconciliation of the numerator and denominator used in the calculation of basic and diluted net (loss) income per share of Class A common stock is as follows (amounts in thousands, except number of shares and per share amounts):
| For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
| 2026 |  | 2025 |  | 2026 |  | 2025
Basic net (loss) income per share: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Net (loss) income | $ | (13,054) |  |  | $ | (7,380) |  |  | $ | 11,080 |  |  | $ | (13,597) |
Less: Net loss attributable to noncontrolling interests | — |  |  | (1,334) |  |  | — |  |  | (2,459) |
Net (loss) income attributable to common shareholders of vTv Therapeutics Inc. | (13,054) |  |  | (6,046) |  |  | 11,080 |  |  | (11,138) |
Denominator: |  |  |  |  |  |  |
Weighted average vTv Therapeutics Inc. Class A common stock (1) | 12,409,316 |  |  | 6,587,070 |  |  | 12,409,297 |  |  | 6,584,969 |
Basic net (loss) income per share of vTv Therapeutics Inc. Class A common stock | $ | (1.05) |  |  | $ | (0.92) |  |  | $ | 0.89 |  |  | $ | (1.69) |
Diluted net (loss) income per share: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Net (loss) income | $ | (13,054) |  |  | $ | (7,380) |  |  | $ | 11,080 |  |  | $ | (13,597) |
Less: Net loss attributable to noncontrolling interests | — |  |  | (1,334) |  |  | — |  |  | (2,459) |
Net (loss) income attributable to common shareholders of vTv Therapeutics Inc | (13,054) |  |  | (6,046) |  |  | 11,080 |  |  | (11,138) |
Denominator: |  |  |  |  |  |  |
Weighted average vTv Therapeutics Inc. Class A common stock (1) | 12,409,316 |  |  | 6,587,070 |  |  | 14,541,788 |  |  | 6,584,969 |
Diluted net (loss) income per share of vTv Therapeutics Inc. Class A common stock | $ | (1.05) |  |  | $ | (0.92) |  |  | $ | 0.76 |  |  | $ | (1.69) |
| (1) | The shares underlying the pre-funded warrants to purchase shares of the Company’s common stock have been included in the calculation of the weighted average number of shares outstanding, basic and diluted, for the three and six months ended June 30, 2026 and 2025.
Schedule of Potentially Dilutive Securities not Included in Calculation of Diluted Net Loss per Share | Potentially dilutive securities not included in the calculation of dilutive net loss per share are as follows:
| June 30, 2026 |  | June 30, 2025
Class B common stock (1) | 92 |  |  | 577,349 |
Common stock options granted under the Plan | 674,538 |  |  | 1,018,250 |
Common stock warrants | 19,160 |  |  | 70,639 |
Total | 693,790 |  |  | 1,666,238 |
___________________________
| (1) | Shares of Class B common stock do not share in the Company’s earnings and are not participating securities. Accordingly, separate presentation of loss per share of Class B common stock under the two-class method has not been provided. Each share of Class B common stock (together with a corresponding vTv Unit) is exchangeable for one share of Class A common stock.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration